These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8101267)

  • 1. Tumour-necrosis-factor antibody treatment in Crohn's disease.
    Derkx B; Taminiau J; Radema S; Stronkhorst A; Wortel C; Tytgat G; van Deventer S
    Lancet; 1993 Jul; 342(8864):173-4. PubMed ID: 8101267
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical treatment of Crohn's disease].
    Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2000 Feb; 97(2):145-52. PubMed ID: 10707582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Crohn's disease].
    Beglinger Ch
    Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Bauditz J; Lochs H; Schreiber S
    N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infliximab-induced hepatitis in a patient with Crohn's disease].
    Soto-Fernández S; González-Carro P; De Pedro-Esteban A; Legaz-Huidobro ML; Pérez-Roldán F; Roncero García-Escribano O; Valbuena-González M; Ruiz-Carrillo F
    Gastroenterol Hepatol; 2006 May; 29(5):321-2. PubMed ID: 16733041
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-TNF antibody treatment of Crohn's disease.
    van Deventer SJ
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumour necrosis factor and Crohn's disease.
    Van Deventer SJ
    Gut; 1997 Apr; 40(4):443-8. PubMed ID: 9176068
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current medical therapies for Crohn's disease in Japan].
    Munakata A; Haga Y
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Hawkey CJ; Stack WA
    N Engl J Med; 1998 Jan; 338(5):333-4. PubMed ID: 9446034
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to tumor necrosis factor in the treatment of Crohn's disease.
    Stricker T; Braegger CP
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):369-70. PubMed ID: 9740217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
    Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
    Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digestive Disease Week 2006. Therapies for Crohn's disease and ulcerative colitis. 21-15 May 2006, Los Angeles, CA, USA.
    Aylett P
    IDrugs; 2006 Jul; 9(7):452-4. PubMed ID: 16821150
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases.
    van Dullemen HM; de Jong E; Slors F; Tytgat GN; van Deventer SJ
    Dis Colon Rectum; 1998 Jan; 41(1):98-102. PubMed ID: 9510318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
    Dignass A; Van Assche G; Lindsay JO; Lémann M; Söderholm J; Colombel JF; Danese S; D'Hoore A; Gassull M; Gomollón F; Hommes DW; Michetti P; O'Morain C; Oresland T; Windsor A; Stange EF; Travis SP;
    J Crohns Colitis; 2010 Feb; 4(1):28-62. PubMed ID: 21122489
    [No Abstract]   [Full Text] [Related]  

  • 18. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E; Pugh S; Fox R
    J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
    [No Abstract]   [Full Text] [Related]  

  • 19. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.
    Malesci A; Angelucci E; Bonifacio C; Sociale O; Omodei P; Repici A; Balzarini L; Danese S
    Inflamm Bowel Dis; 2009 Jun; 15(6):814-5. PubMed ID: 18831523
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody approved for treatment of Crohn's disease.
    Freeman TR; Piascik P
    J Am Pharm Assoc (Wash); 1998; 38(6):770-2. PubMed ID: 9861797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.